In thoracic tumors, loss of SMARCA4 expression occurs in approximately 5% of non-small cell lung cancer (NSCLC) and was associated with more aggressive clinical behavior (Herpel et al. 2017; Velut et al. 2022). This evidence concerns the gene SMARCA4 and neoplasm of thorax.